The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

According to The Business Research Company’s Rotavirus Prophylaxis Global Market Report 2023, the rotavirus prophylaxis market is expected to show promising growth in the forecast period.

The rotavirus prophylaxis market has witnessed remarkable growth in recent years, positioning itself as a crucial component in the realm of preventive healthcare. In 2023, the market size reached $8.15 billion, poised to surge to $9.05 billion in 2024, marking a substantial compound annual growth rate (CAGR) of 11.1%. This growth is attributed to factors such as vaccine access and equity, emerging rotavirus strains, research and development (R&D) investments, and robust public health preparedness.

Key Statistics:

• Market size: $8.15 billion (2023)
• Projected growth: $9.05 billion (2024)
• CAGR: 11.1%

Future Growth Trajectory: A Vision for 2028

Anticipating the future, the rotavirus prophylaxis market is set to continue its robust growth, reaching $13.24 billion in 2028 with a compound annual growth rate (CAGR) of 10.0%. The forecasted growth is fueled by factors such as the burden of gastrointestinal diseases, global expansion, vaccination programs, and the pivotal aspect of vaccine confidence.

Noteworthy Trends:

• Next-generation vaccines
• Combination vaccines
• Vaccine delivery innovation
• Global immunization collaboration

Powering Growth: The Surge in Vaccine Courses

The escalating number of vaccine courses is expected to be a driving force behind the continued growth of the rotavirus prophylaxis market. A vaccine course, defined as a specific dose of vaccine aimed at producing protection against a particular disease, is a pivotal aspect of preventive healthcare. With approximately 5.71 million courses of RV1-5 frozen rotavirus vaccine produced in 2022, projected to increase to 9.31 million by 2028, and 5.29 million courses of RV5-2 lyophilized rotavirus vaccines manufactured in 2022, with a projected rise to 6.13 million courses by 2028, the surge in vaccine courses underscores the market’s trajectory.

Key Driver:

• Increase in vaccine courses

Industry Leaders Steering the Course

Major players in the rotavirus prophylaxis market, including Pfizer Inc., Johnson & Johnson, and GlaxoSmithKline PLC, play a pivotal role in driving market dynamics. These companies contribute to market growth through innovative solutions and strategic initiatives.

Prominent Players:

• Pfizer Inc.
• Johnson & Johnson
• GlaxoSmithKline PLC
• Astra Zeneca Pharmaceuticals LP
• Sanofi SA

Advancements in Vaccine Development and Approvals

Companies operating in the rotavirus prophylaxis market are actively engaged in vaccine development and approvals, adhering to rigorous processes to ensure safety and efficacy. For example, GlaxoSmithKline PLC’s announcement of the FDA approval of an oral-dosing applicator-only presentation of ROTARIX (Rotavirus Vaccine, Live and Oral) in November 2022 signifies a milestone in ensuring access to effective rotavirus prophylaxis.

Noteworthy Development:

• FDA approval of ROTARIX oral-dosing applicator-only presentation

View More On The Rotavirus Prophylaxis Market Report 2023 – https://www.thebusinessresearchcompany.com/report/rotavirus-prophylaxis-global-market-report

Collaborative Strides: Aspen Pharmacare and Serum Institute of India

In August 2022, Aspen Pharmacare Holdings Limited joined hands with Serum Institute of India Pvt. Ltd. to manufacture and sell four Aspen-branded vaccines for Africa. This collaboration aimed to bolster Africa’s health manufacturing capacity and ensure affordable access to vaccines for the African population, including rotavirus prophylaxis.

Collaborative Endeavor:

• Aspen Pharmacare and Serum Institute of India collaboration

Comprehensive Market Segmentation

Navigating the diverse landscape of rotavirus prophylaxis is made possible through comprehensive segmentation. The market is categorized based on treatment, route of administration, distribution channel, and end-users, providing a nuanced understanding of the industry.

Segmentation Highlights:

1. By Treatment: Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments
2. By Route of Administration: Oral, Parenteral, Other Route of Administrations
3. By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4. By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Regional Dynamics: North America Takes the Lead

In 2023, North America emerged as the largest region in the rotavirus prophylaxis market, showcasing the region’s prominence in driving market dynamics.

Regional Dominance:

• North America leads in market size (2023)

Request A Sample Of The Global Rotavirus Prophylaxis Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=13045&type=smp

The Rotavirus Prophylaxis Global Market Report 2023  offers a comprehensive overview on the rotavirus prophylaxis market size, growth rate, trends and drivers, opportunities, strategies, and competitor landscape. The countries covered in the rotavirus prophylaxis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The Table Of Content For The Rotavirus Prophylaxis Market Include:
1. Rotavirus Prophylaxis Market Executive Summary
2. Rotavirus Prophylaxis Market Segments
3. Rotavirus Prophylaxis Market Size And Rotavirus Prophylaxis Market Growth Rate
4. Key Rotavirus Prophylaxis Market Trends
5. Major Rotavirus Prophylaxis Market Drivers
……
25. Key Mergers And Acquisitions In The Rotavirus Prophylaxis Market
26. Top Rotavirus Prophylaxis Companies
27. Rotavirus Prophylaxis Market Opportunities And Strategies
28. Rotavirus Prophylaxis Market, Conclusions And Recommendations
29. Appendix

View More Related Reports –
Meningococcal Vaccines Global Market Report 2023
Typhoid Vi Polysaccharide Vaccine Global Market Report 2023
Veterinary Vaccines Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/ 
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model